Primary Brain Tumor Radiotherapy with Concurrent and Adjuvant Temozolomide: Its Outcomes in Terms of Survival and Toxicity
Background: To assess the outcome of primary brain tumor radiotherapy with concurrent and adjuvant temozolomide. Material and Methods: A total of 42 patients who were histologically proven primary malignant brain tumor with nonmetastatic, ECOG (Eastern Cooperative Oncology Group) performance status...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wolters Kluwer Medknow Publications
2026-04-01
|
| סדרה: | Journal of Pharmacy and Bioallied Sciences |
| נושאים: | |
| גישה מקוונת: | https://journals.lww.com/10.4103/jpbs.jpbs_939_24 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
